Epistem

Epistem

Type: Buyout Capital

Total Originally Invested: £2 million

Initial Investment: June 2018

Sector: Healthcare

Website:

Epistem is a differentiated life sciences services company with headquarters in Manchester and additional facilities in Baltimore, USA.  The Company focuses on providing research services for both pre-clinical and clinical development across several specialist therapeutic areas, including oncology and inflammatory diseases.